Cocrystal Pharma, Inc. (COCP)
1.14
0.00 (0.00%)
USD |
NASDAQ |
Sep 17, 16:00
1.15
+0.01
(+0.88%)
Pre-Market: 08:58
Cocrystal Pharma Price : 1.14 for Sept. 17, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 17, 2026 | 1.14 | 1.150 | 1.121 | 1.14 | 13822.00 |
| Sep 16, 2026 | 1.13 | 1.173 | 1.11 | 1.14 | 46846.00 |
| Sep 15, 2026 | 1.21 | 1.23 | 1.121 | 1.14 | 33986.00 |
| Sep 14, 2026 | 1.27 | 1.27 | 1.17 | 1.17 | 23073.00 |
| Sep 11, 2026 | 1.26 | 1.285 | 1.215 | 1.24 | 58539.00 |
| Sep 10, 2026 | 1.26 | 1.276 | 1.22 | 1.23 | 53602.00 |
| Sep 09, 2026 | 1.18 | 1.29 | 1.175 | 1.24 | 111347.0 |
| Sep 08, 2026 | 1.15 | 1.20 | 1.124 | 1.18 | 61385.00 |
| Sep 04, 2026 | 1.12 | 1.14 | 1.10 | 1.13 | 43422.00 |
| Sep 03, 2026 | 1.16 | 1.16 | 1.12 | 1.13 | 29247.00 |
| Sep 02, 2026 | 1.15 | 1.17 | 1.11 | 1.16 | 56683.00 |
| Sep 01, 2026 | 1.17 | 1.17 | 1.10 | 1.12 | 34756.00 |
| Aug 31, 2026 | 1.10 | 1.16 | 1.10 | 1.16 | 48489.00 |
| Aug 28, 2026 | 1.18 | 1.18 | 1.10 | 1.10 | 28740.00 |
| Aug 27, 2026 | 1.10 | 1.17 | 1.10 | 1.14 | 44943.00 |
| Aug 26, 2026 | 1.13 | 1.17 | 1.115 | 1.12 | 18786.00 |
| Aug 25, 2026 | 1.11 | 1.18 | 1.10 | 1.13 | 71842.00 |
| Aug 24, 2026 | 1.19 | 1.19 | 1.10 | 1.11 | 46044.00 |
| Aug 21, 2026 | 1.19 | 1.21 | 1.10 | 1.15 | 84973.00 |
| Aug 20, 2026 | 1.158 | 1.225 | 1.130 | 1.17 | 175914.0 |
| Aug 19, 2026 | 1.10 | 1.150 | 1.07 | 1.145 | 65376.00 |
| Aug 18, 2026 | 1.08 | 1.11 | 1.07 | 1.08 | 64380.00 |
| Aug 17, 2026 | 1.14 | 1.147 | 1.09 | 1.09 | 30114.00 |
| Aug 14, 2026 | 1.07 | 1.13 | 1.07 | 1.12 | 38298.00 |
| Aug 13, 2026 | 1.11 | 1.15 | 1.10 | 1.10 | 35955.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| CNBX Pharmaceuticals, Inc. | 0.0001 |
| GB Sciences, Inc. | 0.0002 |
| Arvinas, Inc. | 8.31 |
| Fulcrum Therapeutics, Inc. | 3.77 |
| Definium Therapeutics, Inc. | 38.68 |
Price Related Metrics
| PS Ratio | 45.21 |
| Price to Book Value | 15.06 |
| Earnings Yield | -66.55% |
| Market Cap | 15.72M |